Pangaea Oncology, S.A. PANG.MC Stock
Pangaea Oncology, S.A. Price Chart
Pangaea Oncology, S.A. PANG.MC Financial and Trading Overview
| Pangaea Oncology, S.A. stock price | 1.86 EUR |
| Previous Close | 2.14 EUR |
| Open | 2.14 EUR |
| Bid | 0 EUR x 0 |
| Ask | 2.18 EUR x 0 |
| Day's Range | 2.14 - 2.14 EUR |
| 52 Week Range | 1.31 - 2.14 EUR |
| Volume | 800 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 65.15M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PANG.MC Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.5506556 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Pangaea Oncology, S.A. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -13.017% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.14 EUR |
| 52 Week Low | 1.31 EUR |
| 50-Day Moving Average | 1.47 EUR |
| 200-Day Moving Average | 1.46 EUR |
PANG.MC Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 30.44M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 83.97% |
| % Held by Institutions | 0.066% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 4.11M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.839 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Pangaea Oncology, S.A.
| Country | Spain |
| State | N/A |
| City | Barcelona |
| Address | C/ Sabino Arana, 5-19 |
| ZIP | 08028 |
| Phone | 34 93 409 79 81 |
| Website | https://www.panoncology.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients, and pharmaceutical and biotech clients worldwide. It offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, Western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. The company also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development. Pangaea Oncology, S.A. was founded in 2007 and is based in Barcelona, Spain.
Q&A For Pangaea Oncology, S.A. Stock
What is a current PANG.MC stock price?
Pangaea Oncology, S.A. PANG.MC stock price today per share is 1.86 EUR.
How to purchase Pangaea Oncology, S.A. stock?
You can buy PANG.MC shares on the MCE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pangaea Oncology, S.A.?
The stock symbol or ticker of Pangaea Oncology, S.A. is PANG.MC.
Which industry does the Pangaea Oncology, S.A. company belong to?
The Pangaea Oncology, S.A. industry is Diagnostics & Research.
How many shares does Pangaea Oncology, S.A. have in circulation?
The max supply of Pangaea Oncology, S.A. shares is 30.43M.
What is Pangaea Oncology, S.A. Price to Earnings Ratio (PE Ratio)?
Pangaea Oncology, S.A. PE Ratio is now.
What was Pangaea Oncology, S.A. earnings per share over the trailing 12 months (TTM)?
Pangaea Oncology, S.A. EPS is -0.06 EUR over the trailing 12 months.
Which sector does the Pangaea Oncology, S.A. company belong to?
The Pangaea Oncology, S.A. sector is Healthcare.